We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.73B
AUM Growth
+$6.46M
Cap. Flow
-$42.8M
Cap. Flow %
-2.48%
Top 10 Hldgs %
30.81%
Holding
279
New
77
Increased
40
Reduced
47
Closed
83

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$14.4M
2
ILMN icon
Illumina
ILMN
+$11.2M
3
ICUI icon
ICU Medical
ICUI
+$10.4M
4
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$9.5M
5
OM icon
Outset Medical
OM
+$8.23M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
LUNG icon
Pulmonx
LUNG
+$10.1M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$9.8M
5
EVH icon
Evolent Health
EVH
+$7.06M

Sector Composition

Rank Sector Weight
1 Healthcare 34.81%
2 Industrials 0.32%
3 Materials 0.15%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
26
CALL
Intuitive Surgical
ISRG
$143B
$17.8M 1.03%
95,000
+55,000
+138% +$11.8M
NSTG
27
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$17.8M 1.03%
1,390,000
+890,000
+178% +$12.4M
ISEE
28
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$17.5M 1.01%
975,430
+260,286
+36% +$3.42M
ARKK icon
29
PUT
ARK Innovation ETF
ARKK
$6.43B
$17M 0.98%
450,000
– –
ARKG icon
30
PUT
ARK Genomic Revolution ETF
ARKG
$1.78B
$16.4M 0.95%
500,000
-350,000
-41% -$12.8M
ILMN icon
31
CALL
Illumina
ILMN
$28.9B
$16.2M 0.94%
+87,380
New +$17.3M
ELV icon
32
PUT
Elevance Health
ELV
$85.7B
$15.9M 0.92%
+35,000
New +$16.7M
OM icon
33
Outset Medical
OM
$88M
$14.4M 0.83%
60,308
+30,728
+104% +$8.23M
APLS
34
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$13.7M 0.79%
200,000
– –
IMDX
35
Insight Molecular Diagnostics
IMDX
$144M
$13.2M 0.76%
902,814
– –
LUNG icon
36
Pulmonx
LUNG
$98.4M
$13M 0.75%
778,978
-548,087
-41% -$10.1M
SAM icon
37
PUT
Boston Beer
SAM
$1.89B
$12.9M 0.75%
+40,000
New +$13.8M
LYRA
38
DELISTED
LYRA THERAPEUTICS INC
LYRA
$12.6M 0.73%
50,206
-1,318
-3% -$390K
CYTK icon
39
Cytokinetics
CYTK
$10.6B
$12.6M 0.73%
+15,000
New +$722K
IDXX icon
40
PUT
Idexx Laboratories
IDXX
$45.1B
$12.4M 0.72%
38,000
-47,000
-55% -$17.3M
LIVN icon
41
LivaNova
LIVN
$4.48B
$12.3M 0.71%
243,089
-13,759
-5% -$817K
STAA icon
42
STAAR Surgical
STAA
$1.27B
$12.2M 0.71%
173,310
-22,500
-11% -$1.93M
EXAS
43
CALL
DELISTED
Exact Sciences
EXAS
$12.2M 0.71%
375,000
+240,000
+178% +$9.89M
KALV
44
DELISTED
KalVista Pharmaceuticals
KALV
$12.1M 0.7%
832,702
+19,874
+2% +$278K
MEDP icon
45
PUT
Medpace
MEDP
$16.8B
$11.8M 0.68%
75,000
+5,000
+7% +$798K
ISEE
46
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$11.3M 0.65%
629,600
-100,000
-14% -$1.31M
NVCR icon
47
PUT
NovoCure
NVCR
$2.03B
$11M 0.64%
145,100
+55,100
+61% +$4.3M
BAX icon
48
CALL
Baxter International
BAX
$14B
$10.8M 0.63%
+200,700
New +$12.1M
ILMN icon
49
Illumina
ILMN
$28.9B
$10.5M 0.61%
+56,540
New +$11.2M
PACB icon
50
PUT
Pacific Biosciences
PACB
$339M
$9.86M 0.57%
1,700,000
+50,000
+3% +$287K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Pura Vida Investments held 279 positions worth $1.73B, up 0.38% from $1.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2022 filing shows 77 new, 40 increased, 47 reduced and 83 closed positions. Its largest new stake was Illumina: 56,540 shares worth $10.5M. The largest sale was Biogen, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

  • Pura Vida Investments's largest Q3 2022 buy was Illumina: 56,540 shares worth $10.5M.
  • Pura Vida Investments added most to United Therapeutics in Q3 2022, an estimated $14.4M increase.
  • Pura Vida Investments's biggest Q3 2022 reduction was Biogen, cutting an estimated $20.5M.
  • Pura Vida Investments fully exited Alnylam Pharmaceuticals in Q3 2022, selling an estimated $13.9M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $1.73B portfolio in Q3 2022.
  • Pura Vida Investments opened 77 new positions and closed 83 in Q3 2022.
  • Pura Vida Investments's portfolio value rose 0.38% quarter-over-quarter to $1.73B.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.